PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
59.25
ESG score 90-95% of EXEL's 65.77. Bill Ackman would demand clear ESG improvement catalysts.
56.30
Environmental score 80-90% of EXEL's 64.96. Walter Schloss would scrutinize carbon exposure and transition planning.
59.71
Social score 80-90% of EXEL's 67.96. Walter Schloss would scrutinize stakeholder relations and reputational exposure.
61.73
Similar governance score to EXEL's 64.39. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.